# Adverse Drug Reaction-Related Hospital Admissions and Adverse Drug Events and Their Association with Short- and Long-Term Health Outcomes in Older Adults

**Authors:** Juliane Frydenlund, David J. Williams, Frank Moriarty, Emma Wallace, Ciara Kirke, Kathleen Bennett, Caitriona Cahir

PMC · DOI: 10.3390/geriatrics11010011 · Geriatrics · 2026-01-20

## TL;DR

This study explores how adverse drug reactions and events affect health outcomes in older adults over time.

## Contribution

The study investigates the association between adverse drug events and long-term health outcomes in older adults using two prospective cohorts.

## Key findings

- Frailty increased and A&E visits decreased over 3 months in both ADR/non-ADR groups.
- ADEs were associated with lower HRQOL and greater functional decline at both time points.
- Experiencing an ADR or ADE was not significantly linked to changes in health outcomes after adjustments.

## Abstract

Background: This study examined whether adverse drug reaction (ADR)-related hospital admissions or adverse drug events (ADE) in primary care are associated with changes in health-related quality of life (HRQOL), functional decline, and A&E visits, over time, in two separate prospective cohort studies of older adults in Ireland. Methods: The Adverse Drug reactions in an Ageing PopulaTion (ADAPT) (Study 1: N = 230) and the Centre for Primary Care Research (CPCR) (Study 2: N = 605) prospective cohorts were used. Participants completed health outcome questionnaires at baseline and again at 3 months (Study 1) and at 24 months (Study 2). ADR-related admissions and ADEs were assessed at baseline. Multivariable linear, logistic, and ordinal logistic regressions were used to examine associations between ADR-related admissions/ADEs and changes in HRQOL (EQ-5D-5L/3L), functional decline, and A&E visits, adjusting for age, sex, comorbidity, and polypharmacy. Results: In Study 1 (ADAPT cohort), frailty increased and A&E visits decreased over 3 months in both ADR/non-ADR groups (p < 0.01). In Study 2 (CPCR cohort), HRQOL decreased, and functional decline and A&E visits increased for both ADE/non-ADE groups over 24 months (p < 0.05). Individuals with ADEs had lower HRQOL and greater functional decline at both time points (p < 0.001). However, experiencing an ADR or an ADE was not significantly associated with changes in HRQOL, functional decline, or A&E visits over time, after adjustments. Conclusions: There were no substantial differences in the short-term healthcare burden of ADRs, while ADEs had poorer long-term outcomes.

## Full-text entities

- **Diseases:** Frailty (MESH:D000073496), muscle mass (MESH:C536030), rash (MESH:D005076), health problems (MESH:D000076082), fatigue (MESH:D005221), psychiatric (MESH:D001523), anxiety (MESH:D001007), headaches (MESH:D006261), Comorbidity (MESH:D004194), CPCR (MESH:D014947), geriatric syndrome (MESH:D013577), pain/discomfort (MESH:D010146), ADAPT (MESH:D018489), cognitive dysfunction (MESH:D003072), depressed mood (MESH:D003866), muscle pain (MESH:D063806), functional deficits (MESH:D001289), ADE (MESH:D064420), CCI (MESH:C566784), death (MESH:D003643)
- **Chemicals:** A&amp;E (MESH:C538178), levothyroxine (MESH:D013974), 5L (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922001/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922001/full.md

---
Source: https://tomesphere.com/paper/PMC12922001